Discover open access scientific publications

Search, annotate, share and cite publications

Publications by G-N Franke

Monitoring of WT1 Expression in PB and CD34+ Donor Chimerism of BM Predicts Early Relapse in AML and MDS Patients After Hematopoietic Cell Transplantation With Reduced-Intensity Conditioning

Leukemia

English

Related publications

Chimerism and Minimal Residual Disease Monitoring After Reduced Intensity Conditioning (RIC) Allogeneic Transplantation

English

Survival Advantage for Patients With AML and MDS Given Allogeneic Hematopoietic STEM CELL Transplantation Using Myeloablative Versus Reduced Intensity Conditioning (RIC) MAY Become Apparent 5-10 YEARS After Transplantation

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2014

English

Achieving Stringent CR Is Essential Before Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation in AML

Bone Marrow Transplantation

Transplantation

Hematology

2013

English

Missing HLA C Group 1 Ligand in Patients With AML and MDS Is Associated With Reduced Risk of Relapse and Better Survival After Allogeneic Stem Cell Transplantation With Fludarabine and Treosulfan Reduced Toxicity Conditioning

American Journal of Hematology

Hematology

2017

English

Relapse After Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in AML/MDS: Monocyte Chemo-Attractant Protein-1 (MCP-1) Levels Post HCT and Prediction of Relapse in Patients With Hematological Remission and Full Chimerism at Day 30

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2015

English

GvHD-free, Relapse-Free Survival After Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation in Older Patients With Myeloid Malignancies

Bone Marrow Transplantation

Transplantation

Hematology

2016

English

Donor Chimerism in Patients With Primary Immunodeficiency After Allogeneic Hematopoietic Stem Cells Transplantation

English

Donor Mismatch and Acute GVHD Are Associated With Unusually High Mortality in Patients With XIAP Who Underwent Reduced Intensity Conditioning Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2017

English

Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation in Adults With Acute Myeloid Leukemia

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by G-N Franke

Monitoring of WT1 Expression in PB and CD34+ Donor Chimerism of BM Predicts Early Relapse in AML and MDS Patients After Hematopoietic Cell Transplantation With Reduced-Intensity Conditioning

Related publications

Chimerism and Minimal Residual Disease Monitoring After Reduced Intensity Conditioning (RIC) Allogeneic Transplantation

Survival Advantage for Patients With AML and MDS Given Allogeneic Hematopoietic STEM CELL Transplantation Using Myeloablative Versus Reduced Intensity Conditioning (RIC) MAY Become Apparent 5-10 YEARS After Transplantation

Achieving Stringent CR Is Essential Before Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation in AML

Missing HLA C Group 1 Ligand in Patients With AML and MDS Is Associated With Reduced Risk of Relapse and Better Survival After Allogeneic Stem Cell Transplantation With Fludarabine and Treosulfan Reduced Toxicity Conditioning

Relapse After Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in AML/MDS: Monocyte Chemo-Attractant Protein-1 (MCP-1) Levels Post HCT and Prediction of Relapse in Patients With Hematological Remission and Full Chimerism at Day 30

GvHD-free, Relapse-Free Survival After Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation in Older Patients With Myeloid Malignancies

Donor Chimerism in Patients With Primary Immunodeficiency After Allogeneic Hematopoietic Stem Cells Transplantation

Donor Mismatch and Acute GVHD Are Associated With Unusually High Mortality in Patients With XIAP Who Underwent Reduced Intensity Conditioning Hematopoietic Cell Transplantation

Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation in Adults With Acute Myeloid Leukemia